London, Dec 23 (IANS) Faced with a vaccine evading Omicron variant, Oxford university and AstraZeneca announced that they have begun the work to develop a Covid shot that specifically targets the new strain. Early this month, all major drug makers including
London, Nov 13 (IANS) UK vaccine maker AstraZeneca has said that it will cease to provide its Covid vaccine, co-developed with Oxford University, on a not-for-profit basis to countries that can afford it, the media reported. The drugs giant has signed
London, Sep 29 UK drugmaker AstraZeneca has partnered with scientists at Imperial College London to develop a new vaccine technology to treat cancer, heart conditions and other non-infectious diseases and illnesses. The technology was originally intended for targeting Covid-19, and
London, April 28 A single dose of a Pfizer or AstraZeneca vaccine against coronavirus disease can reduce transmission by up to 50 per cent, finds a study. The study led by UK’s Public Health England (PHE) showed that people who
New Delhi, Nov 23 AstraZeneca announced Monday that positive high-level results from an interim analysis of clinical trials of the Covid-19 vaccine candidate in the UK and Brazil showed it was highly effective in preventing the disease, the primary endpoint,
New Delhi, Aug 7 The Serum Institute of India would introduce candidate vaccines from AstraZeneca and Novavax for COVID-19 at less than Rs 250 per dose in India. The Pune-based institute would offer up to 100 million doses at a
Geneva, June 27 After admitting that the world may have a Covid-19 vaccine within one year or even a few months earlier, the World Health Organization (WHO) on Friday said that UK-based AstraZeneca is leading the vaccine race while US-based
 |
 |
 |
|---|---|---|
 |
 |
 |
 |
 |
 |
